SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-08-004374
Filing Date
2008-08-08
Accepted
2008-08-08 17:24:35
Documents
12
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c74405e10vq.htm 10-Q 338646
2 EXHIBIT 10.25 c74405exv10w25.htm EX-10.25 4689
3 EXHIBIT 10.26 c74405exv10w26.htm EX-10.26 5069
4 EXHIBIT 10.27 c74405exv10w27.htm EX-10.27 34837
5 EXHIBIT 10.28 c74405exv10w28.htm EX-10.28 45121
6 EXHIBIT 10.29 c74405exv10w29.htm EX-10.29 28799
7 EXHIBIT 10.30 c74405exv10w30.htm EX-10.30 28551
8 EXHIBIT 31.1 c74405exv31w1.htm EX-31.1 8938
9 EXHIBIT 31.2 c74405exv31w2.htm EX-31.2 8769
10 EXHIBIT 32.1 c74405exv32w1.htm EX-32.1 3269
11 EXHIBIT 32.2 c74405exv32w2.htm EX-32.2 3203
12 GRAPHIC c74405c7440500.gif GRAPHIC 1768
  Complete submission text file 0001362310-08-004374.txt   513897
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 081003690
SIC: 2836 Biological Products, (No Diagnostic Substances)